Hawley’s bills — the Fair Prescription Drug Prices for Americans Act and the Ending the Prescription Drug Kickback Act of 2023 — would penalize pharmaceutical companies for selling drugs in the U.S. at prices that exceed their average costs across the U.S.’s peer nations in the Group of Seven major industrial countries, as well as entirely ban prescription drug rebates in both federal and private health plans.เว็บคาสิโนออนไลน์อันดับ1